GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and blood ...

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Along with weight loss, Faubion’s study found that both groups of women on semaglutide drugs showed improvement in heart health measures like A1C (a marker for diabetes) and blood pressure, although ...